StageAcquired | Acquired
Missing: iPrescribe.net's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: iPrescribe.net's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing iPrescribe.net
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
iPrescribe.net is included in 1 Expert Collection, including Clinical Encounter Tech.
Clinical Encounter Tech
Latest iPrescribe.net News
Jan 12, 2016
Elettromeccanica S.r.l. 's Assets DrFirst , a leading provider of electronic prescribing and secure texting solutions for healthcare providers, announced today it has acquired the assets of iPrescribe.net , a mobile e-prescribing application for iOS and Android devices. The move follows a banner year of investment and growth at DrFirst, which raised $42M in financing in 2015 , including $25 million in equity financing from Goldman Sachs. “We are pleased to launch the new year with this exciting acquisition ,” said G. Cameron Deemer, president of DrFirst. “As we head into 2016, we are committed to further expanding our footprint in key areas of our operations, including e-prescribing, medication management and care collaboration, particularly on mobile platforms. Our strong financial footing enables us to seize new opportunities that align with that mission, both domestically and abroad.” DrFirst leads the electronic prescribing market with Rcopia® and EPCS GoldSM, legend drug and controlled substance e-prescribing technologies, already in use by 330 electronic medical record systems, 1,000 hospitals and 20,000 medical practices nationwide. About DrFirst Named one of the fastest growing companies in North America, DrFirst ( www.drfirst.com ) pioneers electronic prescribing, medication management and secure care collaboration solutions that enhance the doctor-patient point of encounter, optimize provider access to patient information, inform the doctor’s clinical view of the patient and improve care delivery and clinical outcomes. Our growth is driven by a commitment to innovation, security and reliability across a wide array of services. We are proud of our track record of service to more than 330 EMR/EHR/HIS partners and an extensive network of providers, pharmacies, hospitals and post-acute care facilities. Connect with us on Twitter @DrFirst , or on LinkedIn at www.linkedin.com/company/DrFirst . View source version on businesswire.com: http://www.businesswire.com/news/home/20160112005803/en/ DrFirst
iPrescribe.net Frequently Asked Questions (FAQ)
What is iPrescribe.net's latest funding round?
iPrescribe.net's latest funding round is Acquired.
Who are the investors of iPrescribe.net?
Investors of iPrescribe.net include DrFirst.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.